Published date: 4 July 2022

Closed future opportunity - This means that a potential contract has passed its approach to market date. A buyer can choose to consider any supplier interest or convert this notice into an opportunity ready for live procurement.


Approach to market date: 4 July 2022

Contract summary

Industry

  • Research laboratory services - 73111000

Location of contract

SE1 9RT

Value of contract

£180,000

Procurement reference

CCGT-LF-OPEN-0002

Published date

4 July 2022

Approach to market date

4 July 2022

Contract start date

26 September 2022

Contract end date

22 September 2024

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

Yes

Description

Cell Therapy Catapult Ltd is seeking to contract with a suitably capable Bidder to provide the Services for the ribosome profiling of suspension-adapted human cells producing an adeno-associated virus (AAV) vector. The supplier will need to perform laboratory experiments and data analysis. If you are interested in this opportunity please access the tender documents via the link: https://catapultcgtc.wax-live.com/S2C/DisplayModules/TradeModules/Negotiations/Opportunities/ListEvents.aspx?ApplicationInstanceID=27adc89e-0cb2-4b51-9bc1-34061f10156f

More information

Spend profile

This table displays the spend profile of the notice
Financial year Budget
2022/2023 £180,000

About the buyer

Address

12th Floor Tower Wing, Guy's Hospital, Great Maze Pond, London SE1 9RT
London
SE1 9RT
England

Email

procurement@ct.catapult.org.uk